Type 2 Papillary Renal Cell Carcinoma

6 clinical trials · Condition

Record	Firm	Date
Testing Cabozantinib, Crizotinib, Savolitinib and Sunitinib in Kidney Cancer Which Has Progressed (NCT02761057)	National Cancer Institute (NCI)	2016-07-25
Bevacizumab With or Without TRC105 in Treating Patients With Metastatic Kidney Cancer (NCT01727089)	National Cancer Institute (NCI)	2012-11-01
Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot Be Removed by Surgery (NCT01688973)	National Cancer Institute (NCI)	2012-08-20
Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant (NCT00078858)	Fred Hutchinson Cancer Center	2003-09-01
Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer (NCT00027820)	Fred Hutchinson Cancer Center	2001-08-01
Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer (NCT00005799)	Fred Hutchinson Cancer Center	1999-11-01

Every clearance here is in the API, with alerts when new ones post.